Geneesmiddelenbeleid
This procedure is a motion regarding the national pharmaceutical policy of the Netherlands. It seeks to address how medicines are managed, priced, or distributed within the healthcare system to ensure sustainable access to treatment. This affects the Ministry of Health, pharmaceutical companies, and patients who rely on the availability and affordability of essential medications.
National vote coverage: Netherlands-only